Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Type
Blogs Testimonial
Sectors
Agriculture Biotech Chemicals Cosmetics Diagnostics Digital Health Food and Feed Healthcare Medical Devices Pharmaceuticals
Expertises (3)
Advertising and Claims Commercial Contracts Corporate, Governance and Boardroom Counselling Data Protection, (Cyber)security and AI Due Diligence Environmental and Sustainability Financing and M&A Intellectual Property and Licensing Litigation Regulatory Compliance and Enforcement Spin-out and Starter Advisory Subsidies and Grants
Data Protection, (Cyber)security and AI Remove filter Intellectual Property and Licensing Remove filter Financing and M&A Remove filter Clear all

25 results

Newest first
Newest first Oldest first A–Z Z–A
Intellectual Property and Licensing Spin-out and Starter Advisory Blog

Modernised Dutch Patents Act: From Rubber Stamp to Examination

A proposal for the modernisation of the Dutch Patent Act (Rijksoctrooiwet 1995) is currently under consideration by the Parliament. In this article, we briefly outline the most important implications for the Dutch life sciences sector and, in particular, for university spinouts.

Biotech Food and Feed Commercial Contracts Intellectual Property and Licensing Testimonial

A Nordic company owns a proprietary technology for producing legume-based meat alternatives. Axon drafted technology licensing agreements and developed an IP strategy covering patents and trade secrets, with practical checklists for implementation.

Diagnostics Food and Feed Commercial Contracts Intellectual Property and Licensing Spin-out and Starter Advisory Testimonial

Axon assisted a start-up developing a real-time diagnostic test to define pathogens food. We negotiated and drafted an agreement with a university to support the further development & validation of the technology.

Pharmaceuticals Commercial Contracts Intellectual Property and Licensing Testimonial

Axon supports pharmaceutical companies in licensing their products across Europe and beyond. We draft and negotiate licence agreements tailored to each market, helping clients maximise the value of their intellectual property.

Biotech Healthcare Commercial Contracts Intellectual Property and Licensing Testimonial

Axon assists medical technology companies in structuring their collaborations with hospitals and universities. We draft and negotiate cooperation agreements that protect our clients’ IP while fostering innovation.

Healthcare Medical Devices Pharmaceuticals Data Protection, (Cyber)security and AI Testimonial

What distinguishes our lawyers is the ability to see the whole regulatory picture. We have assisted multiple clients, ranging from CROs to pharma start-ups to medical device manufacturers, in setting up GDPR compliance processes and agreements that allow for seamless interaction with other legal frameworks such as MDR and IVDR.

Digital Health Medical Devices Data Protection, (Cyber)security and AI Testimonial

We have assisted a medical device manufacturer in ensuring that their SAAS-application complies with the Data Act and the GDPR.

Medical Devices Data Protection, (Cyber)security and AI Testimonial

We have advised a medical device manufacturer on collaborations with academic institutions on data collection for training of AI systems, including the necessary data protection contracts.

Data Protection, (Cyber)security and AI Testimonial

We have created the data protection strategy for a long-term registry study.

Medical Devices Data Protection, (Cyber)security and AI Testimonial

We have trained the entire regulatory team of a medical device company on understanding GDPR compliance in a clinical research setting.